<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Cell Biology - Latest articles</title>
		<link>http://www.biomedcentral.com/bmccellbiol/</link>
		<description>The latest articles from BMC Cell Biology (ISSN 1471-2121) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/23"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/22"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/21"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/20"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/19"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/18"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/17"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/16"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/14"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/23">
            
            <title>Rapid regulation of protein activity in fission yeast</title>
			<description>Background:
The fission yeast Schizosaccharomyces pombe is widely-used as a model organism for the study of a broad range of eukaryotic cellular processes such as cell cycle, genome stability and cell morphology. Despite the availability of extensive set of genetic, molecular biological, biochemical and cell biological tools for analysis of protein function in fission yeast, studies are often hampered by the lack of an effective method allowing for the rapid regulation of protein level or protein activity.
Results:
In order to be able to regulate protein function, we have made use of a previous finding that the hormone binding domain of steroid receptors can be used as a regulatory cassette to subject the activity of heterologous proteins to hormonal regulation. The approach is based on fusing the protein of interest to the hormone binding domain (HBD) of the estrogen receptor (ER). The HBD tag will attract the Hsp90 complex, which can render the fusion protein inactive. Upon addition of estradiol the protein is quickly released from the Hsp90 complex and thereby activated. We have tagged and characterised the induction of activity of four different HBD-tagged proteins. Here we show that the tag provides the means to effectively regulate the activity of two of these proteins.
Conclusions:
The estradiol-regulatable hormone binding domain provides a means to regulate the function of some, though not all, fission yeast proteins. This system may result in very quick and reversible activation of the protein of interest. Therefore it will be a powerful tool and it will open experimental approaches in fission yeast that have previously not been possible. Since fission yeast is a widely-used model organism, this will be valuable in many areas of research.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/23</link>
			
			 	<dc:creator>Cathrine A Boe, Ignacio Garcia, Chen-Chun Pai, Jeffrey R Sharom, Henriette C Skjolberg, Erik Boye, Stephen Kearsey, Stuart A MacNeill, Michael D Tyers and Beata Grallert</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:23</dc:source>
			<dc:date>2008-05-05</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-23</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>23</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/22">
            
            <title>Application of Bioinformatics-Coupled Experimental Analysis reveals a new Transport-Competent Nuclear Localization Signal in the Nucleoprotein of an Influenza A Virus strain</title>
			<description>Background:
Two nuclear localization sequences (NLS) in influenza A virus nucleoprotein (NP) have been demonstrated to be critical for nuclear import of NP and viral ribonucleoprotein complexes. However, a deletion mutant lacking these two signals was still able to localize to the nucleus suggesting the presence of yet another (a third) potential NLS in the NP protein. In order to identify the nature of this potential NLS signal in the NP of a WS/33L influenza virus A strain, we utilized the tools of bioinformatics coupled with functional experimental analyses  in the present study.
Results:
Comparison of the deduced aa sequence of NP of WS/33L strain with the published WS/33 NP sequences revealed that a single amino acid (aa) change (Met to Arg) at position 105 results in converting the flanking regions (between aa position 90-121, a 32 residue stretch) into two classical overlapping bipartite NLS (obpNLS). GenBank search revealed that 9 out of 500 published NP sequences contain a similar Arg at position 105 (instead of Met) with a 100% homology to the obpNLS region. Various NP-green fluorescent protein (GFP) fusion constructs with and without the signal (obpNLS-Arg 105) were utilized to understand the functional nature of this signal. We analyzed the transport competency of the expressed chimeric proteins in terms of their cellular localization by confocal immunofluorescence assay. Our analysis revealed that all NP-GFP constructs containing the wild-type (R105) sequence localized predominantly to the nucleus. Constructs lacking the obpNLS or constructs with reverse mutation (R105 to M105) on the other hand exhibited predominant cytoplasmic localization pattern. Interestingly, when the 32 aa obpNLS was fused with an unrelated viral protein (rotavirus NSP6) that has been known to be cytoplasmic protein, the chimeric protein (obpNLS-NSP6) was efficiently transported into the nucleus, suggesting the nuclear transport function of the 32-residue obpNSL in the NP of WS/33L strain of influenza virus A. 
Conclusion:
This report while not only establishing a new NLS in the influenza virus A strain, it also reinforces the idea that proper application of bioinformatics-coupled experimental analysis serves as a powerful tool in identifying new functional signals in proteins of interest.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/22</link>
			
			 	<dc:creator>Krishna Mohan V Ketha and Chintamani D Atreya</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:22</dc:source>
			<dc:date>2008-04-28</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-22</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>22</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/21">
            
            <title>Disruption of Four Kinesin Genes in Dictyostelium</title>
			<description>Background:
Kinesin and dynein are the two families of microtubule-based motors that drive much of the intracellular movements in eukaryotic cells. Using a gene knockout strategy, we address here the individual function(s) of four of the 13 kinesin proteins in Dictyostelium. The goal of our ongoing project is to establish a minimal motility proteome for this basal eukaryote, enabling us to contrast motor functions here with the often far more elaborate motor families in the metazoans.
Results:
We performed individual disruptions of the kinesin genes, kif4, kif8, kif10, and kif11. None of the motors encoded by these genes are essential for development or viability of Dictyostelium. Removal of Kif4 (kinesin-7; CENP-E family) significantly impairs the rate of cell growth and, when combined with a previously characterized dynein inhibition, results in dramatic defects in mitotic spindle assembly. Kif8 (kinesin-4; chromokinesin family) and Kif10 (kinesin-8; Kip3 family) appear to cooperate with dynein to organize the interphase radial microtubule array.
Conclusions:
The results reported here extend the number of kinesin gene disruptions in Dictyostelium, to now total 10, among the 13 isoforms. None of these motors, individually, are required for short-term viability. In contrast, homologs of at least six of the 10 kinesins are considered essential in humans. Our work underscores the functional redundancy of motor isoforms in basal organisms while highlighting motor specificity in more complex metazoans. Since motor disruption in Dictyostelium can readily be combined with other motility insults and stresses, this organism offers an excellent system to investigate functional interactions among the kinesin motor family.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/21</link>
			
			 	<dc:creator>Dilip K Nag, Irina Tikhonenko, Ikko Soga and Michael P Koonce</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:21</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-21</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/20">
            
            <title>Postnatal stem/progenitor cells derived from the dental pulp of adult chimpanzee  </title>
			<description>Background:
Chimpanzee dental pulp stem/stromal cells (ChDPSCs) are very similar to human bone marrow derived mesenchymal stem/stromal cells (hBMSCs) as demonstrated by the expression pattern of cell surface markers and their multipotent differentiation capability. 
Results:
ChDPSCs were isolated from an incisor and a canine of a forty-seven year old female chimpanzee. A homogenous population of ChDPSCs was established in early culture at a high proliferation rate and verified by the expression pattern of thirteen cell surface markers. The ChDPSCs are multipotent and were capable of differentiating into osteogenic, adipogenic and chondrogenic lineages under appropriate in vitro culture conditions. ChDPSCs also express stem cell (Sox-2, Nanog, Rex-1, Oct-4) and osteogenic (Osteonectin, osteocalcin, osteopontin) markers, which is comparable to reported results of rhesus monkey BMSCs (rBMSCs), hBMSCs and hDPSCs. Although ChDPSCs vigorously proliferated during the initial phase and gradually decreased in subsequent passages, the telomere length indicated that telomerase activity was not significantly reduced. 
Conclusions:
These results demonstrate that ChDPSCs can be efficiently isolated from post-mortem teeth of adult chimpanzees and are multipotent. Due to the almost identical genome composition of humans and chimpanzees, there is an emergent need for defining the new role of chimpanzee modeling in comparative medicine. Teeth are easy to recover at necropsy and easy to preserve prior to the retrieval of dental pulp for stem/stromal cells isolation. Therefore, the establishment of ChDPSCs would preserve and maximize the applications of such a unique and invaluable animal model, and could advance the understanding of cellular functions and differentiation control of adult stem cells in higher primates. </description>
			<link>http://www.biomedcentral.com/1471-2121/9/20</link>
			
			 	<dc:creator>Pei-Hsun Cheng, Brooke Snyder, Dimitri Fillos, Chris C Ibegbu, Anderson Hsien-Cheng Huang and Anthony W.S. Chan</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:20</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-20</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/19">
            
            <title>The influence of nicotine on granulocytic differentiation &#8211; Inhibition of the oxidative burst and bacterial killing and increased matrix metalloproteinase-9 release</title>
			<description>Background:
Neutrophils leave the bone marrow as terminally differentiated cells, yet little is known of the influence of nicotine or other tobacco smoke components on neutrophil differentiation. Therefore, promyelocytic HL-60 cells were differentiated into neutrophils using dimethylsulfoxide in the presence and absence of nicotine (3-(1-methyl-2-pyrrolidinyl) pyridine). Differentiation was evaluated over 5 days by monitoring terminal differentiation markers (CD11b expression and formazan deposition); cell viability, growth phase, kinetics, and apoptosis; assessing cellular morphology and ultrastructure; and conformational changes to major cellular components. Key neutrophil effector functions (oxidative burst, bacterial killing, matrix metalloproteinase release) were also examined.
Results:
Nicotine increased the percentage of cells in late differentiation phases (metamyelocytes, banded neutrophils and segmented neutrophils) compared to DMSO alone (p &lt; 0.05), but did not affect any other marker of neutrophil differentiation examined. However, nicotine exposure during differentiation suppressed the oxidative burst in HL-60 cells (p &lt; 0.001); inhibited bacterial killing (p &lt; 0.01); and increased the LPS-induced release of MMP-9, but not MMP-2 (p &lt; 0.05). These phenomena may be &#945;-7-acetylcholine nicotinic receptor-dependent. Furthermore, smokers exhibited an increased MMP-9 burden compared to non-smokers in vivo (p &lt; 0.05).
Conclusion:
These findings may partially explain the known increase in susceptibility to bacterial infection and neutrophil-associated destructive inflammatory diseases in individuals chronically exposed to nicotine.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/19</link>
			
			 	<dc:creator>Minqi Xu, James E Scott, Kan-Zhi Liu, Hannah R Bishop, Diane E Renaud, Richard M Palmer, Abdel Soussi-Gounni and David A Scott</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:19</dc:source>
			<dc:date>2008-04-15</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-19</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/18">
            
            <title>A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery</title>
			<description>Background:
Several human pathologies, including neoplasia and ischemic cardiovascular diseases, course with an unbalance between oxygen supply and demand (hypoxia). Cells within hypoxic regions respond with the induction of a specific genetic program, under the control of the Hypoxia Inducible Factor (HIF), that mediates their adaptation to the lack of oxygen. The activity of HIF is mainly regulated by the EGL-nine homolog (EGLN) enzymes that hydroxylate the alpha subunit of this transcription factor in an oxygen-dependent reaction. Hydroxylated HIF is then recognized and ubiquitinilated by the product of the tumor suppressor gene, pVHL, leading to its proteosomal degradation. Under hypoxia, the hydroxylation of HIF by the EGLNs is compromised due to the lack of oxygen, which is a reaction cosubstrate. Thus, HIF escapes degradation and drives the transcription of its target genes. Since the progression of the aforementioned pathologies might be influenced by activation of HIF-target genes, development of small molecules with the ability to interfere with the HIF-regulatory machinery is of great interest.
Results:
Herein we describe a yeast three-hybrid system that reconstitutes mammalian HIF regulation by the EGLNs and VHL. In this system, yeast growth, under specific nutrient restrictions, is driven by the interaction between the &#946; domain of VHL and a hydroxyproline-containing HIF&#945; peptide. In turn, this interaction is strictly dependent on EGLN activity that hydroxylates the HIF&#945; peptide. Importantly, this system accurately preserves the specificity of the hydroxylation reaction toward specific substrates. We propose that this system, in combination with a matched control, can be used as a simple and inexpensive assay to identify molecules that specifically modulate EGLN activity. As a proof of principle we show that two known EGLN inhibitors, dimethyloxaloylglycine (DMOG) and 6-chlor-3-hydroxychinolin-2-carbonic acid-N-carboxymethylamide (S956711), have a profound and specific effect on the yeast HIF/EGLN/VHL system.
Conclusion:
The system described in this work accurately reconstitutes HIF regulation while preserving EGLN substrate specificity. Thus, it is a valuable tool to study HIF regulation, and particularly EGLN biochemistry, in a cellular context. In addition, we demonstrate that this system can be used to identify specific inhibitors of the EGLN enzymes.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/18</link>
			
			 	<dc:creator>Maria L Alcaide-German, Alicia Vara-Vega, Luis F Garcia-Fernandez, Manuel O Landazuri and Luis del Peso</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:18</dc:source>
			<dc:date>2008-04-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-18</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/17">
            
            <title>Spatial separation and bidirectional trafficking of proteins using a multi-functional reporter</title>
			<description>Background:
The ability to specifically label proteins within living cells can provide information about their dynamics and function. To study a membrane protein, we fused a multi-functional reporter protein, HaloTag&#174;, to the extracellular domain of a truncated integrin.
Results:
Using the HaloTag technology, we could study the localization, trafficking and processing of an integrin-HaloTag fusion, which we showed had cellular dynamics consistent with native integrins. By labeling live cells with different fluorescent impermeable and permeable ligands, we showed spatial separation of plasma membrane and internal pools of the integrin-HaloTag fusion, and followed these protein pools over time to study bi-directional trafficking. In addition to combining the HaloTag reporter protein with different fluorophores, we also employed an affinity tag to achieve cell capture.
Conclusion:
The HaloTag technology was used successfully to study expression, trafficking, spatial separation and real-time translocation of an integrin-HaloTag fusion, thereby demonstrating that this technology can be a powerful tool to investigate membrane protein biology in live cells.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/17</link>
			
			 	<dc:creator>Soshana Svendsen, Chad Zimprich, Mark G McDougall, Dieter H Klaubert and Georgyi V Los</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:17</dc:source>
			<dc:date>2008-04-02</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-17</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/16">
            
            <title>Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit</title>
			<description>Background:
Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this signalling pathway is regulated is required. It has recently been demonstrated that inhibition of cAMP-dependent protein kinase (PKA) induces a ligand-independent internalization of EGFR. Cyclic-AMP-dependent protein kinase consists of a regulatory dimer bound to two catalytic subunits.
Results:
We have investigated the effect on EGFR levels after ablating the two catalytic subunits, C&#945; and C&#946; in two different models. The first model used targeted disruption of either C&#945; or C&#946; in mice whereas the second model used C&#945; and C&#946; RNA interference in HeLa cells. In both models we observed a significant reduction of EGFR expression at the protein but not mRNA level.
Conclusion:
Our results suggest that PKA may represent a target that when manipulated can maintain EGFR protein levels at the single cell level as well as in intact animals.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/16</link>
			
			 	<dc:creator>Morten P Oksvold, Ane Funderud, Anne-Katrine Kvissel, Ellen Skarpen, Heidi Henanger, Henrik S Huitfeldt, Bj&#248;rn S Sk&#229;lhegg and Sigurd &#216;rstavik</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:16</dc:source>
			<dc:date>2008-04-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-16</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/15">
            
            <title>A novel semi-automatic image processing approach to determine Plasmodium falciparum parasitemia in Giemsa-stained thin blood smears</title>
			<description>Background:
Malaria parasitemia is commonly used as a measurement of the amount of parasites in the patient's blood and a crucial indicator for the degree of infection. Manual evaluation of Giemsa-stained thin blood smears under the microscope is onerous, time consuming and subject to human error. Although automatic assessments can overcome some of these problems the available methods are currently limited by their inability to evaluate cases that deviate from a chosen "standard" model.
Results:
In this study reliable parasitemia counts were achieved even for sub-standard smear and image quality. The outcome was assessed through comparisons with manual evaluations of more than 200 sample smears and related to the complexity of cell overlaps. On average an estimation error of less than 1% with respect to the average of manually obtained parasitemia counts was achieved. In particular the results from the proposed approach are generally within one standard deviation of the counts provided by a comparison group of malariologists yielding a correlation of 0.97. Variations occur mainly for blurred out-of-focus imagery exhibiting larger degrees of cell overlaps in clusters of erythrocytes.The assessment was also carried out in terms of precision and recall and combined in the F-measure providing results generally in the range of 92% to 97% for a variety of smears. In this context the observed trade-off relation between precision and recall guaranteed stable results. Finally, relating the F-measure with the degree of cell overlaps, showed that up to 50% total cell overlap can be tolerated if the smear image is well-focused and the smear itself adequately stained.
Conclusion:
The automatic analysis has proven to be comparable with manual evaluations in terms of accuracy. Moreover, the test results have shown that the proposed comparison-based approach, by exploiting the interrelation between different images and color channels, has successfully overcome most of the inherent limitations possibly occurring during the sample preparation and image acquisition phase. Eventually, this can be seen as an opportunity for developing low-cost solutions for mass screening.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/15</link>
			
			 	<dc:creator>Minh-Tam Le, Timo R Bretschneider, Claudia Kuss and Peter R Preiser</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:15</dc:source>
			<dc:date>2008-03-28</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/14">
            
            <title>Xenopus importin beta validates human importin beta as a cell cycle negative regulator</title>
			<description>Background:
Human importin beta has been used in all Xenopus laevis in vitro nuclear assembly and spindle assembly studies. This disconnect between species raised the question for us as to whether importin beta was an authentic negative regulator of cell cycle events, or a dominant negative regulator due to a difference between the human and Xenopus importin beta sequences. No Xenopus importin beta gene was yet identified at the time of those studies. Thus, we first cloned, identified, and tested the Xenopus importin beta gene to address this important mechanistic difference. If human importin beta is an authentic negative regulator then we would expect human and Xenopus importin beta to have identical negative regulatory effects on nuclear membrane fusion and pore assembly. If human importin beta acts instead as a dominant negative mutant inhibitor, we should then see no inhibitory effect when we added the Xenopus homologue.
Results:
We found that Xenopus importin beta acts identically to its human counterpart. It negatively regulates both nuclear membrane fusion and pore assembly. Human importin beta inhibition was previously found to be reversible by Ran for mitotic spindle assembly and nuclear membrane fusion, but not nuclear pore assembly. During the present study, we observed that this differing reversibility varied depending on the presence or absence of a tag on importin beta. Indeed, when untagged importin beta, either human or Xenopus, was used, inhibition of nuclear pore assembly proved to be Ran-reversible.
Conclusion:
We conclude that importin beta, human or Xenopus, is an authentic negative regulator of nuclear assembly and, presumably, spindle assembly. A difference in the Ran sensitivity between tagged and untagged importin beta in pore assembly gives us mechanistic insight into nuclear pore formation.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/14</link>
			
			 	<dc:creator>Valerie A Delmar, Rene C Chan and Douglass J Forbes</dc:creator>
			
			<dc:source>BMC Cell Biology 2008, 9:14</dc:source>
			<dc:date>2008-03-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-14</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
